Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab
Clinical trial NCT01403610 · COMPLETED
Trial details
- NCT number
- NCT01403610
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.